Plasmablastic lymphoma with unfavorable chromosomal abnormalities related to plasma cell myeloma: A borderline case between plasmablastic lymphoma and plasmablastic plasma cell myeloma.
作者信息
Aoyama Yumi, Tsunemine Hiroko, Kodaka Taiichi, Oda Nao, Matsuoka Hirofumi, Itoh Tomoo, Takahashi Takayuki
机构信息
Departments of Hematology, Shinko Hospital.
Respiratory Medicine, Shinko Hospital.
出版信息
J Clin Exp Hematop. 2017;57(1):37-39. doi: 10.3960/jslrt.16020.
Abstract
摘要
相似文献
1
Plasmablastic lymphoma with unfavorable chromosomal abnormalities related to plasma cell myeloma: A borderline case between plasmablastic lymphoma and plasmablastic plasma cell myeloma.伴有与浆细胞骨髓瘤相关的不良染色体异常的浆母细胞淋巴瘤：浆母细胞淋巴瘤与浆母细胞性浆细胞骨髓瘤之间的交界病例。
J Clin Exp Hematop. 2017;57(1):37-39. doi: 10.3960/jslrt.16020.
2
Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features.具有 MYC 易位的浆母细胞淋巴瘤：在浆母细胞特征产生中存在共同途径的证据。
Mod Pathol. 2010 Jul;23(7):991-9. doi: 10.1038/modpathol.2010.72. Epub 2010 Mar 26.
3
Lymphoid Neoplasms With Plasmablastic Differentiation: A Comprehensive Review and Diagnostic Approaches.具有浆母细胞分化的淋巴肿瘤：全面综述和诊断方法。
Adv Anat Pathol. 2020 Mar;27(2):61-74. doi: 10.1097/PAP.0000000000000253.
4
Plasmablastic lymphoma versus anaplastic myeloma in a human immunodeficiency virus negative male: a diagnostic quandary.HIV 阴性男性的浆母细胞淋巴瘤与间变大细胞性骨髓瘤：诊断难题。
Arch Iran Med. 2013 Oct;16(10):608-10.
5
Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma.中国台湾的浆细胞骨髓瘤常表现为骨髓外和结外肿块，类似于浆细胞淋巴瘤。
Virchows Arch. 2022 Aug;481(2):283-293. doi: 10.1007/s00428-022-03342-3. Epub 2022 Jun 3.
6
CD31 expression in plasmacytic/plasmablastic lesions.浆细胞性/浆母细胞性病变中的CD31表达。
Ann Diagn Pathol. 2013 Dec;17(6):498-501. doi: 10.1016/j.anndiagpath.2013.08.003. Epub 2013 Sep 24.
7
[Plasmablastic myeloma initially presented with ascites].浆母细胞性骨髓瘤最初表现为腹水。
Rinsho Ketsueki. 2022;63(3):194-200. doi: 10.11406/rinketsu.63.194.
8
Cutaneous localization of plasmablastic multiple myeloma with heterotopic expression of CD3 and CD4: Skin involvement revealing systemic disease.伴有CD3和CD4异位表达的浆母细胞性多发性骨髓瘤的皮肤定位：皮肤受累揭示全身性疾病。
J Cutan Pathol. 2019 Aug;46(8):619-622. doi: 10.1111/cup.13486. Epub 2019 May 10.
9
[Plasmablastic lymphoma presenting clinical symptoms similar to plasmablastic myeloma].表现出与浆母细胞性骨髓瘤相似临床症状的浆母细胞性淋巴瘤
Rinsho Ketsueki. 2023;64(4):260-264. doi: 10.11406/rinketsu.64.260.
10
Plasmablastic haemato-lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib.具有伯基特淋巴瘤复杂遗传特征的浆母细胞性血液淋巴肿瘤，对硼替佐米有反应。
Hematol Oncol. 2013 Sep;31(3):164-6. doi: 10.1002/hon.2024. Epub 2012 Aug 17.
引用本文的文献
1
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.商业 CAR T 细胞治疗后 T 细胞淋巴瘤和继发原发性恶性肿瘤风险。
Nat Med. 2024 Apr;30(4):984-989. doi: 10.1038/s41591-024-02826-w. Epub 2024 Jan 24.
2
Case report: simultaneous occurrence of multiple myeloma and non-Hodgkin lymphoma treated by CAR T therapy.病例报告：接受嵌合抗原受体T细胞（CAR T）疗法治疗的多发性骨髓瘤与非霍奇金淋巴瘤同时发生
Medicine (Baltimore). 2020 Apr;99(16):e19739. doi: 10.1097/MD.0000000000019739.
本文引用的文献
1
Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis.浆母细胞淋巴瘤：临床病理特征与鉴别诊断综述
Arch Pathol Lab Med. 2016 Oct;140(10):1074-8. doi: 10.5858/arpa.2016-0232-RA.
2
Extramedullary manifestation in multiple myeloma bears high incidence of poor cytogenetic aberration and novel agents resistance.多发性骨髓瘤的髓外表现具有细胞遗传学异常不良和对新型药物耐药的高发生率。
Biomed Res Int. 2015;2015:787809. doi: 10.1155/2015/787809. Epub 2015 Apr 23.
3
The biology and treatment of plasmablastic lymphoma.浆母细胞淋巴瘤的生物学特性与治疗。
Blood. 2015 Apr 9;125(15):2323-30. doi: 10.1182/blood-2014-10-567479. Epub 2015 Jan 30.
4
Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival.骨髓瘤 IFM99 试验的长期分析：细胞遗传学异常 [t(4;14)、del(17p)、1q 增益] 在定义长期生存方面发挥着重要作用。
J Clin Oncol. 2012 Jun 1;30(16):1949-52. doi: 10.1200/JCO.2011.36.5726. Epub 2012 Apr 30.
5
Plasmablastic lymphoma: a systematic review.浆母细胞淋巴瘤：一项系统综述
ScientificWorldJournal. 2011 Mar 22;11:687-96. doi: 10.1100/tsw.2011.59.
6
Plasmablastic lymphoma in an immunocompetent patient.
J Clin Oncol. 2009 Sep 1;27(25):e78-81. doi: 10.1200/JCO.2009.22.2208. Epub 2009 Jul 6.
7
BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation.在无BCL2基因易位的滤泡性淋巴瘤中，BCL6基因扩增/3q27获得与独特的临床病理特征相关。
Mod Pathol. 2008 Aug;21(8):973-8. doi: 10.1038/modpathol.2008.75. Epub 2008 May 23.
8
Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.浆母细胞淋巴瘤和浆母细胞性浆细胞骨髓瘤具有几乎相同的免疫表型特征。
Mod Pathol. 2005 Jun;18(6):806-15. doi: 10.1038/modpathol.3800355.
9
HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum.人类免疫缺陷病毒（HIV）与发生于鼻窦、睾丸及骨骼的浆母细胞淋巴瘤：疾病谱的进一步扩展
Am J Hematol. 2004 Nov;77(3):291-5. doi: 10.1002/ajh.20190.
10
Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma.
Blood. 1998 Sep 1;92(5):1743-8.
Zotero 插件